ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI says SELECT study is close to full enrollment.

April 23, 2004

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

May 14, 1993

NCI Establishes New Program Project Grant Guidelines.

January 13, 2006

NCI Launches $18M Program to Encourage Produce Consumption

July 17, 1992